-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Regarding the layoffs of some sales teams that have been hotly discussed a few days ago, Mengdi China Pharmaceuticals recently disclosed to Cyberland exclusively that Mengdi China currently has no layoff plans
.
01
01Mengdi China: No layoffs for talent retention plan
Mengdi China: No layoffs for talent retention planRecently, in response to the talent retention program launched by Mengdi China Pharmaceuticals, it is reported that employees on the list will be retained to work until June next year, and an additional 20,000 yuan bonus will be issued; employees who are not on the list will be retained or laid off without compensation.
.
.
Regarding the above statement, Mengdi China Pharmaceuticals clearly pointed out to Cyberland: So far, Mengdi China has no layoff plan.
On the contrary, the talent retention program we launched is to motivate and retain talents, not to lay off employees
.
According to reports, Mundi China Pharmaceutical’s talent retention program was officially launched in early August this year, and it is currently the first phase of the retention program for sales talents
.
The above plan is an extra benefit item for outstanding employees in addition to the regular salary and welfare plan
.
Its coverage levels range from sales representatives to regional sales directors, covering more than 40% of the total sales staff
02
02All-round compliance is the shortlisted standard
All-round compliance is the shortlisted standardWhich employees are expected to be included?
Which employees are expected to be included?Mengdi China Pharmaceuticals told Cyberlan that first is the employees who have completed the probation period; second is the achievement of personal performance; there is also a very important point is "compliance"-all employees, including pharmaceutical representatives, must regularly participate in the company's Online compliance testing and interaction with medical professionals must also strictly abide by the company’s compliance regulations
.
The above-mentioned person stated to Cyberland that the company's considerations for launching the first batch of talent retention programs facing the sales team are:
First, the sales team is the team with the largest number of employees in the company, accounting for more than 50%.
As an important talent pool of the company, incentives first start with a large number of people and a wide range of benefits; secondly, considering that the sales team, as a front-line employee, faces greater challenges during the epidemic.
I still made contributions to the company under the challenge, and I hope this project will bring them more motivation to move forward; in addition, under the influence of the overall environment, the sales team’s talent flow is relatively large, and I hope that this will encourage and retain more talents.
There are many employees who have development potential, are willing to work hard, and grow together with the company; in the end, this plan also fully reflects the thoughtfulness and care of Mundi Pharmaceuticals for employees
.
At present, the most outstanding, outstanding and relatively good employees and potential employees in the sales team are basically included in the plan, the person told Cyberlan
.
Mengdi China further stated that, judging from the feedback currently received by the company's human resources department, the overall feedback from employees who have been included in the talent retention program is positive-some of the previous information was not accurate
.
Moreover, Mengdi China has plans to implement a follow-up talent retention plan based on the overall development situation to continue to encourage and retain more outstanding talents
.
03
03Exclusive response to sales rumors
Exclusive response to sales rumorsThe reason why some social media inferred from Mundi China’s talent retention plan that it will lay off employees based on relevant sources may be related to Mundi’s recent sales rumors and the background of the intensive structural adjustment of multinational pharmaceutical companies
.
In this regard, Mengdi China exclusively stated to Cyberland that the company has not received any information from official channels, so there is no way to comment
.
Regarding the so-called layoff plan, Mundi China further stated to Cyberland, “As a leading company in the field of pain management in China, the current corporate development strategy of Mundi China Pharmaceuticals has not changed for the time being
.
” The company also has no plans for product adjustments, so large-scale layoffs do not exist
What needs to be explained is that the talent retention program itself is not universal.
Some people have it and some don't; some people have it first, and some people have it later
.
The purpose is also to hope that employees who have not been included can improve their personal performance and ability through their own efforts.
04
04The anxiety of medical representatives being laid off
The anxiety of medical representatives being laid offCyberlan believes that it must be admitted that from a broader industry background, it is understandable that sales employees such as medical representatives have the anxiety of being laid off
.
Since the 4+7 centralized procurement pilot, up to now, the implementation of five rounds of mass procurement has had a real impact on many multinational pharmaceutical companies
.
The series of medical insurance and medical policies that bear the brunt of mass purchases have initiated the deep adjustment of China's pharmaceutical industry
Original research drugs have truly ushered in the patent cliff in China, the prices of generic drugs have fallen, and innovative drugs are also facing the lowest price reduction requirements in the world.
Just look at the team adjustment, but within half a year, Huizhi abolished the North China Retail Chronic Illness Team; Eli Lilly first gradually adjusted the sales team of Cialis outside the hospital, and then directly sold the ownership of Cialis; because the market accounted for more than half of the Propofol medium/long chain fat emulsion successfully won the bid, Fresenius Kabi’s anesthesia line began to lay off; earlier in March, the Japanese pharmaceutical company Daiichi Sankyo announced the abolition of part of its anti-infection and respiratory analgesia product line Regional medical representative
In addition, it is not uncommon for domestic pharmaceutical companies to abolish sales representatives.
Returning to the group of millions of people represented by the pharmaceutical industry, due to the policy attributes of the pharmaceutical industry itself and the instability of its profession, under the background that the expansion of medical insurance has entered a stable period and the main policy adjustment stock, it will only go further.
Regardless of whether it is facing team adjustments or product line abolitions, what pharmaceutical representatives can do is to calm their minds, protect themselves, and take advantage of the trend
In the atmosphere where layoffs and anxiety are spreading, in the face of the new human incentive measures introduced by pharmaceutical companies, medical representatives may wish to wait and see the changes